New Oxadiazole/ Benzimidazole Hybrids: Design, Synthesis, and Molecular Docking Studies.
Last updated: 03 Jan 2025
10.21608/jabps.2023.190430.1179
Benzimidazole, 1,3,4-oxadiazole, EGFR inhibitors
Fatma
Hagar
Department of Medicinal Chemistry, Faculty of Pharmacy, Minia University, 61519-Minia, Egypt.
drfatmafouad@gmail.com
Samar
Abbas
H
Department of Medicinal Chemistry, Faculty of Pharmacy, Minia University, 61519-Minia, Egypt
drsamar77@hotmail.com
Minia
0000-0002-9586-2644
Ahmed
Sayed
M
Pharmacognosy Department, School of Pharmacy, Nahda University, Beni-Suef, Egypt.
ahmedpharma8530@gmail.com
Beni Suef
Dalia
Abdelhamid
Department of Medicinal Chemistry, Faculty of Pharmacy, Minia University, 61519-Minia, Egypt.
dalia_abdelhameed@mu.edu.eg
Mohamed
Osman
Medicinal Chemistry Department, Faculty of Pharmacy, Minia University.
abulnil@hotmail.com
Minia
6
2
40490
2023-04-01
2023-01-29
2023-04-01
97
106
2535-1869
2535-2040
https://jabps.journals.ekb.eg/article_290882.html
https://jabps.journals.ekb.eg/service?article_code=290882
6
Original Article
522
Journal
Journal of advanced Biomedical and Pharmaceutical Sciences
https://jabps.journals.ekb.eg/
New Oxadiazole/ Benzimidazole Hybrids: Design, Synthesis, and Molecular Docking Studies.
Details
Type
Article
Created At
23 Dec 2024